DATA generated through Guyana’s national health voucher programme is playing a central role in shaping the       country’s evidence-based health-care planning.

This is according to Minister of Health Dr Frank Anthony, who recently stated that this data allows the Ministry of Health to identify disease trends earlier and further design targeted interventions in this regard.

“These vouchers are very important, not just because of the testing, but because of what we are able to do with the results,” he said

He noted that the health authorities are able to analyse what is going on in certain areas and further ensure the relevant care reaches them. “From the data, we are able to analyse what is going on in our population and reach out to people, bring them into care and manage the problems that they have,” he added.

Against this backdrop, the minister said that over the past two years, more than 461,000 vouchers have been processed across eye care, laboratory testing and cancer screening.

The volume of results, he added, now allows the ministry to stratify data by region, sex, locality and disease type, providing insights that were previously unavailable at a national level.

One area where the data is already influencing policy is chronic-disease management.

“Because we have this information, we can now bring them into care and work with them before the disease progresses,” he stated.

The data have also highlighted links between long-standing diabetes and kidney failure, prompting the introduction of new medications aimed at delaying the onset of renal disease in high-risk patients.

Additionally, cancer detection has similarly benefitted from the programme’s analytical capacity, even as eye-care screenings have led to the identification of cataracts and glaucoma, while laboratory data have supported earlier diagnosis of prostate cancer through PSA testing.

HPV screening results have informed the expansion of vaccination strategies and follow-up care for women at risk of cervical cancer.

“This is not just a transactional relationship,” Dr Anthony told health-care service providers.

He added, “The utilisation of what we test and how we use that information is what is helping us to do our work better.”

To this end, he said that the continuous flow of data is also shaping the future direction of the programme itself, including proposed additions such as ultrasound services and expanded diabetic eye screening, based on demonstrated public need.

“If we are able to get people earlier, using the information that we now have, we can prevent many of these conditions from progressing,” he said.